{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,17]],"date-time":"2026-10-17T08:45:18Z","timestamp":1792226718095,"version":"4.4.0"},"reference-count":68,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"42","license":[{"start":{"date-parts":[[2024,10,18]],"date-time":"2024-10-18T00:00:00Z","timestamp":1729209600000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2024,10,18]]},"abstract":"<jats:p>Ferroptosis is iron-dependent programmed cell death that inhibits tumor growth, particularly in traditional treatment-resistant tumors. Prognostic models constructed from ferroptosis-related genes are lacking; prognostic biomarkers remain insufficient. We acquired gene expression data and corresponding clinical information for bladder cancer (BC) samples from public databases. Ferroptosis-related genes from the ferroptosis database were screened for clinical predictive value. We validated gene expression differences between tumors and normal tissues through polymerase chain reaction and western blotting. Gene ontology and Kyoto encyclopedia of genes and genomes enrichment analyses were conducted to explore signaling pathways affecting the overall survival of patients with BC. CIBERSORT was used to quantify the infiltration of 22 immune cell types. We identified 6 genes (EGFR, FADS1, ISCU, PGRMC1, PTPN6, and TRIM26) to construct the prognostic risk model. The high-risk group had a poorer overall survival than the low-risk group. Receiver operating characteristic curves demonstrated excellent predictive accuracy. The validation cohort and 3 independent datasets confirmed the models\u2019 general applicability and stability. BC tissues had elevated FADS1, PTPN6, and TRIM26 mRNA and protein levels and decreased ISCU levels. Enrichment analysis indicated that neurosecretory activity might be the main pathway affecting the overall survival. High- and low-risk groups had significantly different immune cell infiltration. Specific ferroptosis-related gene expression was associated with immune cell infiltration levels. The risk score was significantly correlated with patients\u2019 clinical characteristics. A novel, widely applicable risk model with independent predictive value for the prognosis of patients with BC was established; candidate molecules for future BC research were identified.<\/jats:p>","DOI":"10.1097\/md.0000000000040133","type":"journal-article","created":{"date-parts":[[2024,10,28]],"date-time":"2024-10-28T18:04:35Z","timestamp":1730138675000},"page":"e40133","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":7,"title":["Construction and multiple validations of a robust ferroptosis-related prognostic model in bladder cancer: A comprehensive study"],"prefix":"10.1097","volume":"103","author":[{"given":"Xianyu","family":"Dai","sequence":"first","affiliation":[{"name":"Urology Department, First Hospital of Jilin University, Changchun, Jilin Province, China."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kai","family":"Yu","sequence":"additional","affiliation":[{"name":"Urology Department, First Hospital of Jilin University, Changchun, Jilin Province, China."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hongjie","family":"Wang","sequence":"additional","affiliation":[{"name":"Urology Department, First Hospital of Jilin University, Changchun, Jilin Province, China."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rong","family":"Zhong","sequence":"additional","affiliation":[{"name":"Urology Department, First Hospital of Jilin University, Changchun, Jilin Province, China."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhongqi","family":"Zhang","sequence":"additional","affiliation":[{"name":"Urology Department, First Hospital of Jilin University, Changchun, Jilin Province, China."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3900-2065","authenticated-orcid":false,"given":"Yuchuan","family":"Hou","sequence":"additional","affiliation":[{"name":"Urology Department, First Hospital of Jilin University, Changchun, Jilin Province, China."}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-20250503","doi-asserted-by":"crossref","first-page":"675651","DOI":"10.3389\/fmolb.2021.675651","article-title":"Construction and external validation of a ferroptosis-related gene signature of predictive value for the overall survival in bladder cancer.","volume":"8","author":"Liu","year":"2021","journal-title":"Front Mol Biosci"},{"key":"R2-20250503","doi-asserted-by":"crossref","first-page":"6976","DOI":"10.1002\/jcp.27440","article-title":"Chromatin-regulatory genes served as potential therapeutic targets for patients with urothelial bladder carcinoma.","volume":"234","author":"Qiu","year":"2019","journal-title":"J Cell Physiol"},{"key":"R3-20250503","doi-asserted-by":"crossref","first-page":"394","DOI":"10.3322\/caac.21492","article-title":"Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries.","volume":"68","author":"Bray","year":"2018","journal-title":"CA Cancer J Clin"},{"key":"R4-20250503","doi-asserted-by":"crossref","first-page":"7","DOI":"10.3322\/caac.21654","article-title":"Cancer statistics, 2021.","volume":"71","author":"Siegel","year":"2021","journal-title":"CA Cancer J Clin"},{"key":"R5-20250503","doi-asserted-by":"crossref","first-page":"3181","DOI":"10.3390\/cancers14133181","article-title":"Advances in diagnosis and therapy for bladder cancer.","volume":"14","author":"Hu","year":"2022","journal-title":"Cancers"},{"key":"R6-20250503","doi-asserted-by":"crossref","first-page":"778973","DOI":"10.3389\/fphar.2021.778973","article-title":"Functional nanomedicines for targeted therapy of bladder cancer.","volume":"12","author":"Tang","year":"2021","journal-title":"Front Pharmacol"},{"key":"R7-20250503","first-page":"1647","article-title":"Autophagy modulation in bladder cancer development and treatment (Review).","volume":"42","author":"Li","year":"2019","journal-title":"Oncol Rep"},{"key":"R8-20250503","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1016\/j.eururo.2016.05.041","article-title":"EAU guidelines on non-muscle-invasive urothelial carcinoma of the bladder: update 2016.","volume":"71","author":"Babjuk","year":"2017","journal-title":"Eur Urol"},{"key":"R9-20250503","doi-asserted-by":"crossref","first-page":"2796","DOI":"10.1016\/S0140-6736(16)30512-8","article-title":"Bladder cancer.","volume":"388","author":"Kamat","year":"2016","journal-title":"Lancet"},{"key":"R10-20250503","doi-asserted-by":"crossref","first-page":"814735","DOI":"10.3389\/fcell.2022.814735","article-title":"Integrated analysis of energy metabolism signature-identified distinct subtypes of bladder urothelial carcinoma.","volume":"10","author":"Zhang","year":"2022","journal-title":"Front Cell Dev Biol"},{"key":"R11-20250503","doi-asserted-by":"crossref","first-page":"1060","DOI":"10.1016\/j.cell.2012.03.042","article-title":"Ferroptosis: an iron-dependent form of nonapoptotic cell death.","volume":"149","author":"Dixon","year":"2012","journal-title":"Cell"},{"key":"R12-20250503","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1038\/s41571-020-00462-0","article-title":"Broadening horizons: the role of ferroptosis in cancer.","volume":"18","author":"Chen","year":"2021","journal-title":"Nat Rev Clin Oncol"},{"key":"R13-20250503","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1038\/s41580-020-00324-8","article-title":"Ferroptosis: mechanisms, biology and role in disease.","volume":"22","author":"Jiang","year":"2021","journal-title":"Nat Rev Mol Cell Biol"},{"key":"R14-20250503","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1038\/s41419-020-2298-2","article-title":"Ferroptosis: past, present and future.","volume":"11","author":"Li","year":"2020","journal-title":"Cell Death Dis"},{"key":"R15-20250503","doi-asserted-by":"crossref","first-page":"920","DOI":"10.1016\/j.cmet.2020.10.011","article-title":"The metabolic underpinnings of ferroptosis.","volume":"32","author":"Zheng","year":"2020","journal-title":"Cell Metab"},{"key":"R16-20250503","doi-asserted-by":"crossref","first-page":"478","DOI":"10.1016\/j.tcb.2020.02.009","article-title":"Emerging mechanisms and disease relevance of ferroptosis.","volume":"30","author":"Stockwell","year":"2020","journal-title":"Trends Cell Biol"},{"key":"R17-20250503","doi-asserted-by":"crossref","first-page":"1904197","DOI":"10.1002\/adma.201904197","article-title":"Recent progress in ferroptosis inducers for cancer therapy.","volume":"31","author":"Liang","year":"2019","journal-title":"Adv Mater"},{"key":"R18-20250503","doi-asserted-by":"crossref","first-page":"414","DOI":"10.1186\/s12935-021-02096-3","article-title":"A novel signature constructed by ferroptosis-associated genes (FAGs) for the prediction of prognosis in bladder urothelial carcinoma (BLCA) and associated with immune infiltration.","volume":"21","author":"Luan","year":"2021","journal-title":"Cancer Cell Int"},{"key":"R19-20250503","doi-asserted-by":"crossref","first-page":"11291","DOI":"10.2147\/OTT.S232852","article-title":"Ferroptosis in carcinoma: regulatory mechanisms and new method for cancer therapy.","volume":"12","author":"Shi","year":"2019","journal-title":"Onco Targets Ther"},{"key":"R20-20250503","doi-asserted-by":"crossref","first-page":"101942","DOI":"10.1016\/j.redox.2021.101942","article-title":"Quiescin sulfhydryl oxidase 1 promotes sorafenib-induced ferroptosis in hepatocellular carcinoma by driving EGFR endosomal trafficking and inhibiting NRF2 activation.","volume":"41","author":"Sun","year":"2021","journal-title":"Redox Biol"},{"key":"R21-20250503","doi-asserted-by":"crossref","first-page":"1028","DOI":"10.1038\/s41419-021-04306-2","article-title":"Fin56-induced ferroptosis is supported by autophagy-mediated GPX4 degradation and functions synergistically with mTOR inhibition to kill bladder cancer cells.","volume":"12","author":"Sun","year":"2021","journal-title":"Cell Death Dis"},{"key":"R22-20250503","doi-asserted-by":"crossref","first-page":"623","DOI":"10.1016\/j.chembiol.2019.01.008","article-title":"Imidazole ketone erastin induces ferroptosis and slows tumor growth in a mouse lymphoma model.","volume":"26","author":"Zhang","year":"2019","journal-title":"Cell Chem Biol"},{"key":"R23-20250503","doi-asserted-by":"crossref","first-page":"5429","DOI":"10.2147\/OTT.S254995","article-title":"The role of erastin in ferroptosis and its prospects in cancer therapy.","volume":"13","author":"Zhao","year":"2020","journal-title":"Onco Targets Ther"},{"key":"R24-20250503","doi-asserted-by":"crossref","first-page":"baaa021","DOI":"10.1093\/database\/baaa021","article-title":"FerrDb: a manually curated resource for regulators and markers of ferroptosis and ferroptosis-disease associations.","volume":"2020","author":"Zhou","year":"2020","journal-title":"Database (Oxford)"},{"key":"R25-20250503","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1038\/nmeth.3337","article-title":"Robust enumeration of cell subsets from tissue expression profiles.","volume":"12","author":"Newman","year":"2015","journal-title":"Nat Methods"},{"key":"R26-20250503","doi-asserted-by":"crossref","first-page":"686044","DOI":"10.3389\/fonc.2021.686044","article-title":"A novel prognostic model based on ferroptosis-related gene signature for bladder cancer.","volume":"11","author":"Yang","year":"2021","journal-title":"Front Oncol"},{"key":"R27-20250503","doi-asserted-by":"crossref","first-page":"e0276453","DOI":"10.1371\/journal.pone.0276453","article-title":"The clinical efficacy and safety of equipment-assisted intravesical in stillation of mitomycin C after transurethral resection of bladder tum our in patients with nonmuscular invasive bladder cancer: a meta-analysis.","volume":"17","author":"Zhou","year":"2022","journal-title":"PLoS One"},{"key":"R28-20250503","doi-asserted-by":"crossref","first-page":"647","DOI":"10.3892\/ol.2015.3337","article-title":"Aberrant methylation of CDH11 predicts a poor outcome for patients with bladder cancer.","volume":"10","author":"Lin","year":"2015","journal-title":"Oncol Lett"},{"key":"R29-20250503","doi-asserted-by":"crossref","first-page":"676","DOI":"10.1186\/s12935-021-02264-5","article-title":"Roles of ferroptosis in urologic malignancies.","volume":"21","author":"Zhao","year":"2021","journal-title":"Cancer cell Int"},{"key":"R30-20250503","doi-asserted-by":"crossref","first-page":"4045","DOI":"10.1016\/j.apsb.2021.03.036","article-title":"Baicalin induces ferroptosis in bladder cancer cells by downregulating FTH1.","volume":"11","author":"Kong","year":"2021","journal-title":"Acta Pharmaceutica Sinica B"},{"key":"R31-20250503","doi-asserted-by":"crossref","first-page":"775506","DOI":"10.3389\/fphar.2021.775506","article-title":"Natural product erianin inhibits bladder cancer cell growth by inducing ferroptosis via NRF2 inactivation.","volume":"12","author":"Xiang","year":"2021","journal-title":"Front Pharmacol"},{"key":"R32-20250503","doi-asserted-by":"crossref","first-page":"6794","DOI":"10.1080\/21655979.2022.2036909","article-title":"Bupivacaine modulates the apoptosis and ferroptosis in bladder cancer via phosphatidylinositol 3-kinase (PI3K)\/AKT pathway.","volume":"13","author":"Hao","year":"2022","journal-title":"Bioengineered"},{"key":"R33-20250503","doi-asserted-by":"crossref","first-page":"5144","DOI":"10.3390\/ijms24065144","article-title":"HSPA5 promotes the proliferation, metastasis and regulates ferroptosis of bladder cancer.","volume":"24","author":"Wang","year":"2023","journal-title":"Int J Mol Sci"},{"key":"R34-20250503","doi-asserted-by":"crossref","first-page":"8201","DOI":"10.3390\/cimb45100517","article-title":"Ferroptosis: an emerging target for bladder cancer therapy.","volume":"45","author":"Shan","year":"2023","journal-title":"Curr Issues Mol Biol"},{"key":"R35-20250503","doi-asserted-by":"crossref","first-page":"631152","DOI":"10.3389\/fmolb.2021.631152","article-title":"Biological functions and prognostic value of ferroptosis-related genes in bladder cancer.","volume":"8","author":"Yi","year":"2021","journal-title":"Front Mol Biosci"},{"key":"R36-20250503","doi-asserted-by":"crossref","first-page":"1073","DOI":"10.3390\/genes13061073","article-title":"Robust prediction of prognosis and immunotherapy response for bladder cancer through machine learning algorithm.","volume":"13","author":"Hu","year":"2022","journal-title":"Genes (Basel)"},{"key":"R37-20250503","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1186\/s12957-022-02514-4","article-title":"Predictive role of ferroptosis-related long non-coding RNAs in bladder cancer and their association with immune microenvironment and immunotherapy response.","volume":"20","author":"Liu","year":"2022","journal-title":"World J Surg Oncol"},{"key":"R38-20250503","doi-asserted-by":"crossref","first-page":"730716","DOI":"10.3389\/fonc.2021.730716","article-title":"Identification of a novel ferroptosis-related gene prognostic signature in bladder cancer.","volume":"11","author":"Sun","year":"2021","journal-title":"Front Oncol"},{"key":"R39-20250503","doi-asserted-by":"crossref","first-page":"e076743","DOI":"10.1136\/bmj-2023-076743","article-title":"Advances in diagnosis and treatment of bladder cancer.","volume":"384","author":"Lopez-Beltran","year":"2024","journal-title":"Bmj"},{"key":"R40-20250503","doi-asserted-by":"crossref","first-page":"3221","DOI":"10.1038\/s41467-018-05074-y","article-title":"Identification of susceptibility pathways for the role of chromosome 15q25.1 in modifying lung cancer risk.","volume":"9","author":"Ji","year":"2018","journal-title":"Nat Commun"},{"key":"R41-20250503","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1038\/nrc1252","article-title":"Cytokines in cancer pathogenesis and cancer therapy.","volume":"4","author":"Dranoff","year":"2004","journal-title":"Nat Rev Cancer"},{"key":"R42-20250503","doi-asserted-by":"crossref","first-page":"3804","DOI":"10.1172\/JCI57099","article-title":"Breast cancer stem cells, cytokine networks, and the tumor microenvironment.","volume":"121","author":"Korkaya","year":"2011","journal-title":"J Clin Invest"},{"key":"R43-20250503","doi-asserted-by":"crossref","first-page":"2547","DOI":"10.1016\/j.celrep.2017.02.054","article-title":"Oncogene-selective sensitivity to synchronous cell death following modulation of the amino acid nutrient cystine.","volume":"18","author":"Poursaitidis","year":"2017","journal-title":"Cell Rep"},{"key":"R44-20250503","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1002\/1878-0261.12155","article-title":"Emerging functions of the EGFR in cancer.","volume":"12","author":"Sigismund","year":"2018","journal-title":"Mol Oncol"},{"key":"R45-20250503","doi-asserted-by":"crossref","first-page":"942798","DOI":"10.3389\/fonc.2022.942798","article-title":"Fatty acid desaturase 1 (FADS1) is a cancer marker for patient surviva l and a potential novel target for precision cancer treatment.","volume":"12","author":"Heravi","year":"2022","journal-title":"Front Oncol"},{"key":"R46-20250503","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1006\/geno.2000.6196","article-title":"cDNA cloning, genomic structure, and chromosomal localization of three members of the human fatty acid desaturase family.","volume":"66","author":"Marquardt","year":"2000","journal-title":"Genomics"},{"key":"R47-20250503","doi-asserted-by":"crossref","first-page":"8325","DOI":"10.2147\/CMAR.S254316","article-title":"Identification of FADS1 through common gene expression profiles for predicting survival in patients with bladder cancer.","volume":"12","author":"Jiao","year":"2020","journal-title":"Cancer Manag Res"},{"key":"R48-20250503","doi-asserted-by":"crossref","first-page":"16497","DOI":"10.1038\/srep16497","article-title":"Regulation of iron homeostasis by the p53-ISCU pathway.","volume":"5","author":"Funauchi","year":"2015","journal-title":"Sci Rep"},{"key":"R49-20250503","doi-asserted-by":"crossref","first-page":"350","DOI":"10.1186\/s13046-021-02168-2","article-title":"PGRMC1-dependent lipophagy promotes ferroptosis in paclitaxel-tolerant persister cancer cells.","volume":"40","author":"You","year":"2021","journal-title":"J Exp Clin Cancer Res"},{"key":"R50-20250503","doi-asserted-by":"crossref","first-page":"5204","DOI":"10.1021\/acs.biochem.6b00756","article-title":"A novel role for progesterone receptor membrane component 1 (PGRMC1): a partner and regulator of ferrochelatase.","volume":"55","author":"Piel","year":"2016","journal-title":"Biochemistry"},{"key":"R51-20250503","doi-asserted-by":"crossref","first-page":"R85","DOI":"10.1186\/bcr2155","article-title":"Breast cancer proteomics reveals correlation between estrogen receptor status and differential phosphorylation of PGRMC1.","volume":"10","author":"Neubauer","year":"2008","journal-title":"Breast Cancer Res"},{"key":"R52-20250503","doi-asserted-by":"crossref","first-page":"E1","DOI":"10.1002\/ijc.26432","article-title":"Elevated progesterone receptor membrane component 1\/sigma-2 receptor levels in lung tumors and plasma from lung cancer patients.","volume":"131","author":"Mir","year":"2012","journal-title":"Int J Cancer"},{"key":"R53-20250503","doi-asserted-by":"crossref","first-page":"1592","DOI":"10.1210\/jc.2007-2771","article-title":"Regulation of ovarian cancer cell viability and sensitivity to cisplatin by progesterone receptor membrane component-1.","volume":"93","author":"Peluso","year":"2008","journal-title":"J Clin Endocrinol Metab"},{"key":"R54-20250503","doi-asserted-by":"crossref","first-page":"e0170453","DOI":"10.1371\/journal.pone.0170453","article-title":"PGRMC1 is a novel potential tumor biomarker of human renal cell carcinoma based on quantitative proteomic and integrative biological assessments.","volume":"12","author":"Zhang","year":"2017","journal-title":"PLoS One"},{"key":"R55-20250503","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1155\/2020\/8866730","article-title":"The analysis of PTPN6 for bladder cancer: an exploratory study based on TCGA.","volume":"2020","author":"Shen","year":"2020","journal-title":"Dis Markers"},{"key":"R56-20250503","doi-asserted-by":"crossref","first-page":"7333","DOI":"10.1038\/s41467-021-27452-9","article-title":"A targetable LIFR\u2212NF-\u03baB\u2212LCN2 axis controls liver tumorigenesis and vulnerability to ferroptosis.","volume":"12","author":"Yao","year":"2021","journal-title":"Nat Commun"},{"key":"R57-20250503","doi-asserted-by":"crossref","first-page":"644901","DOI":"10.3389\/fcell.2021.644901","article-title":"TRIM26 induces ferroptosis to inhibit hepatic stellate cell activation and mitigate liver fibrosis through mediating SLC7A11 ubiquitination.","volume":"9","author":"Zhu","year":"2021","journal-title":"Front Cell Dev Biol"},{"key":"R58-20250503","doi-asserted-by":"crossref","first-page":"19019","DOI":"10.1002\/jcp.28541","article-title":"Overexpression of TRIM26 suppresses the proliferation, metastasis, and glycolysis in papillary thyroid carcinoma cells.","volume":"234","author":"Wang","year":"2019","journal-title":"J Cell Physiol"},{"key":"R59-20250503","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1038\/s41419-023-06048-9","article-title":"TRIM26 inhibited osteosarcoma progression through destabilizing RACK1 and thus inactivation of MEK\/ERK signaling.","volume":"14","author":"Xia","year":"2023","journal-title":"Cell Death Dis"},{"key":"R60-20250503","doi-asserted-by":"crossref","first-page":"458","DOI":"10.1016\/j.bbrc.2015.05.117","article-title":"TRIM26 functions as a novel tumor suppressor of hepatocellular carcinoma and its downregulation contributes to worse prognosis.","volume":"463","author":"Wang","year":"2015","journal-title":"Biochem Biophys Res Commun"},{"key":"R61-20250503","doi-asserted-by":"crossref","first-page":"4606","DOI":"10.18632\/aging.204102","article-title":"Comprehensive analysis of expression profiles and prognosis of TRIM genes in human kidney clear cell carcinoma.","volume":"14","author":"Shen","year":"2022","journal-title":"Aging (Albany NY)"},{"key":"R62-20250503","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1002\/kjm2.12194","article-title":"Overexpression of tripartite motif containing 26 inhibits non-small cell lung cancer cell growth by suppressing PI3K\/AKT signaling.","volume":"36","author":"Tao","year":"2020","journal-title":"Kaohsiung J Med Sci"},{"key":"R63-20250503","doi-asserted-by":"crossref","first-page":"109366","DOI":"10.1016\/j.cbi.2021.109366","article-title":"Knockdown of TRIM26 inhibits the proliferation, migration and invasion of bladder cancer cells through the Akt\/GSK3beta\/beta-catenin pathway.","volume":"337","author":"Xie","year":"2021","journal-title":"Chem Biol Interact"},{"key":"R64-20250503","doi-asserted-by":"crossref","first-page":"2803","DOI":"10.7150\/ijbs.81726","article-title":"TRIM26 promotes non-small cell lung cancer survival by inducing PBX1 degradation.","volume":"19","author":"Sun","year":"2023","journal-title":"Int J Biol Sci"},{"key":"R65-20250503","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1002\/pros.24068","article-title":"High intratumoral CD8+ T-cell infiltration is associated with improved survival in prostate cancer patients undergoing radical prostatectomy.","volume":"81","author":"Yang","year":"2021","journal-title":"The Prostate"},{"key":"R66-20250503","doi-asserted-by":"crossref","first-page":"1678","DOI":"10.3389\/fimmu.2020.01678","article-title":"Identification of an immune signature predicting prognosis risk and lymphocyte infiltration in colon cancer.","volume":"11","author":"Li","year":"2020","journal-title":"Front Immunol"},{"key":"R67-20250503","doi-asserted-by":"crossref","first-page":"726486","DOI":"10.3389\/fonc.2021.726486","article-title":"A novel prognostic signature based on ferroptosis-related genes predicts the prognosis of patients with advanced bladder urothelial carcinoma.","volume":"11","author":"Li","year":"2021","journal-title":"Front Oncol"},{"key":"R68-20250503","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1093\/annonc\/mdy495","article-title":"Development of tumor mutation burden as an immunotherapy biomarker: utility for the oncology clinic.","volume":"30","author":"Chan","year":"2019","journal-title":"Ann Oncol"}],"container-title":["Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/MD.0000000000040133","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,5,4]],"date-time":"2025-05-04T00:19:13Z","timestamp":1746317953000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/MD.0000000000040133"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,10,18]]},"references-count":68,"journal-issue":{"issue":"42","published-print":{"date-parts":[[2024]]}},"URL":"https:\/\/doi.org\/10.1097\/md.0000000000040133","relation":{},"ISSN":["1536-5964"],"issn-type":[{"value":"1536-5964","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,10,18]]}}}